American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update

被引：278

作者：

Blonde, Lawrence ^{[1
]}

Umpierrez, Guillermo E. ^{[2
]}

Reddy, S. Sethu ^{[3
]}

McGill, Janet B. ^{[4
]}

Berga, Sarah L. ^{[5
]}

Bush, Michael ^{[6
]}

Chandrasekaran, Suchitra ^{[2
]}

DeFronzo, Ralph A. ^{[7
]}

Einhorn, Daniel ^{[8
]}

Gardner, Thomas W. ^{[9
]}

Garg, Rajesh ^{[10
]}

Garvey, W. Timothy ^{[11
]}

Hirsch, Irl B. ^{[12
]}

Hurley, Daniel L. ^{[13
]}

Izuora, Kenneth ^{[14
]}

Kosiborod, Mikhail ^{[15
]}

Olson, Darin ^{[16
]}

Patel, Shailendra B. ^{[17
]}

Pop-Busui, Rodica ^{[9
]}

Sadhu, Archana R. ^{[18
,19
,20
]}

Samson, Susan L. ^{[21
]}

Stec, Carla ^{[22
]}

Tamborlane, William V., Jr. ^{[23
]}

Tuttle, Katherine R. ^{[24
,25
,26
]}

Twining, Christine ^{[27
]}

Vella, Adrian

Vellanki, Priyathama ^{[13
]}

Weber, Sandra L. ^{[2
,28
]}

机构：

[1] Ochsner Hlth, New Orleans, LA USA

[2] Emory Univ, Atlanta, GA USA

[3] Cent Michigan Univ, Mt Pleasant, MI USA

[4] Washington Univ St Louis, St Louis, MO USA

[5] SUNY Buffalo, Buffalo, NY USA

[6] Cedars Sinai, Beverly Hills, CA USA

[7] Univ Texas San Antonio, San Antonio, TX USA

[8] Scripps Whittier Diabet Inst, La Jolla, CA USA

[9] Univ Michigan, Ann Arbor, MI USA

[10] Harbor UCLA Med Ctr, Lundquist Inst, Torrance, CA USA

[11] Univ Alabama Birmingham, Birmingham, AL USA

[12] Univ Washington, Seattle, WA USA

[13] Mayo Clin, Rochester, MN USA

[14] Univ Nevadae Las Vegas, Las Vegas, NV USA

[15] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

[16] Colorado Mt Med LLC, Avon, CO USA

[17] Univ Cincinnati, Med Ctr, Cincinnati, OH USA

[18] Houston Methodist, Houston, TX USA

[19] Weill Cornell Med, Houston, TX USA

[20] Texas A&M Coll Med, Houston, TX USA

[21] Mayo Clin, Jacksonville, FL USA

[22] Amer Assoc Clin Endocrinol, Jacksonville, FL USA

[23] Yale Sch Med, New Haven, CT USA

[24] Univ Washington, Seattle, WA USA

[25] Providence Hlth Care, Seattle, WA USA

[26] Providence Hlth Care, Spokane, WA USA

[27] Maine Med Ctr, Scarborough, ME USA

[28] Univ South Carolina, Sch Med Greenville, Prisma Hlth Syst, Greenville, SC USA

来源：

ENDOCRINE PRACTICE | 2022年 / 28卷 / 10期

关键词：

antihyperglycemic medications; atherosclerotic cardiovascular disease; cardiovascular diseases; diabetes; gestational; diabetes mellitus; type; 1; 2; diabetic nephropathies; diabetic neuropathies; diabetic retinopathy; dyslipidemias; guideline; hospitalization; hypertension; hypoglycemia; infertility; interdisciplinary communication; metabolic syndrome; obesity; occupations; prediabetic state; pregnancy; secondary diabetes; sleep apnea syndromes; telemedicine; vaccination; CHRONIC KIDNEY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; INTENSIVE INSULIN THERAPY; DENSITY-LIPOPROTEIN-CHOLESTEROL; SELF-MANAGEMENT EDUCATION; OBSTRUCTIVE SLEEP-APNEA; ALL-CAUSE MORTALITY;

D O I：

10.1016/j.eprac.2022.08.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and stakeholders, and individuals with diabetes and their caregivers. Methods: The American Association of Clinical Endocrinology selected a task force of medical experts and staff who updated and assessed clinical questions and recommendations from the prior 2015 version of this guideline and conducted literature searches for relevant scientific papers published from January 1, 2015, through May 15, 2022. Selected studies from results of literature searches composed the evidence base to update 2015 recommendations as well as to develop new recommendations based on review of clinical evidence, current practice, expertise, and consensus, according to established American Association of Clinical Endocrinology protocol for guideline development. Results: This guideline includes 170 updated and new evidence-based clinical practice recommendations for the comprehensive care of persons with diabetes. Recommendations are divided into four sections: (1) screening, diagnosis, glycemic targets, and glycemic monitoring; (2) comorbidities and complications, including obesity and management with lifestyle, nutrition, and bariatric surgery, hypertension, dyslipidemia, retinopathy, neuropathy, diabetic kidney disease, and cardiovascular disease; (3) management of prediabetes, type 2 diabetes with antihyperglycemic pharmacotherapy and glycemic targets, type 1 diabetes with insulin therapy, hypoglycemia, hospitalized persons, and women with diabetes in pregnancy; (4) education and new topics regarding diabetes and infertility, nutritional supplements, secondary diabetes, social determinants of health, and virtual care, as well as updated recommendations on cancer risk, nonpharmacologic components of pediatric care plans, depression, education and team approach, occupational risk, role of sleep medicine, and vaccinations in persons with diabetes. Conclusions: This updated clinical practice guideline provides evidence-based recommendations to assist with person-centered, team-based clinical decision-making to improve the care of persons with diabetes mellitus. (c) 2022 AACE. Published by Elsevier Inc. All rights reserved.

引用

页码：923 / 1049

页数：127

共 1851 条

[81] Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association [J].